This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
Thank you. Just saw this as well. I have only been waiting for 10 YEARS! Hope this is good enough for FDA approval.
Lisa, mom to 3, one 11 year old w/cf
Does anybody know what the data given so far, translates to percentages? All I have heard is that there is "decrease in decline of function" and decreased exacerbations, but I get the feeling that the results haven't been as dramatic as the avg 10% seen with Kalydeco (ivacaftor) Congrats to all you nonsense mutations!
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.